Observational study supports adding CAC score to traditional risk factors for precision medicine approach
Cleveland Clinic findings prompt efforts for broad data pooling
Results inform dose selection for further trials of the aldosterone synthase inhibitor
Benefits of new FDA safety determination go beyond expanding patients’ options
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Additional analyses of the two trials presented at 2023 ESC Congress
Rates of CR eligibility high and internet access low among older patients in rural areas
Catch up with our latest volumes and outcomes data
Lower success rates, more hospital MACE seen with poor-quality distal targets
Number of stent layers correlates with worse outcomes
Surgery is typically the only option for the most severe cases, but a minimally invasive procedure is reducing morbidity and recovery time for patients
Advertisement
Advertisement